Literature DB >> 32394592

Expanding criteria for slow colonic transit in patients being evaluated for chronic constipation by scintigraphy.

Katayoun Khoshbin1, Irene Busciglio1, Duane Burton1, Margaret K Breen-Lyles1, Michael Camilleri1.   

Abstract

BACKGROUND: Colonic transit measurement [geometric center (GC) at 24 and 48 hours] identifies slow transit constipation (STC) in patients with chronic constipation. AIM: To evaluate the utility of the difference between GC24 and GC48 (Δ48-24 ) to identify STC in adults with chronic constipation.
METHODS: We reviewed medical records of 250 patients, aged 18-75 years, who underwent colonic transit by scintigraphy during 1994-2019 for investigation of chronic constipation. Data collected included demographics, medical and surgical histories, and anorectal manometry. We used colonic transit from 220 healthy controls to identify the 5th percentile for diagnosing STC: 1.3 at 24 hours, and 1.9 at 48 hours. In addition, the 5th percentile for Δ48-24 was 0.38 for females and 0.29 for males. Data are reported as median and IQR [Q1, Q3]). KEY
RESULTS: Among the 250 patients [median age 42.5 years (IQR 30.75, 56), 84% female], based on GC24 < 1.3, 52 (20.8%) had STC (3 males, 49 females); and based on GC48 < 1.9, 28(11.2%) had STC (3 males, 25 females). Colonic transit was normal in 74.8%. In the groups with normal GC24 and GC48, Δ48-24 identified an additional 32(15.1%) of 212 female patients and 4 (10.5%) of 38 male patients with slow progression of colonic transit between 24 and 48 hours. Among these 36 patients with abnormal Δ48-24 , 13(36.1%) had evidence of rectal evacuation disorder. CONCLUSIONS & INFERENCES: Δ48-24 measurement on scintigraphic colonic transit can identify an additional 9.2% of STC in patients with constipation without rectal evacuation disorder and can help individualize treatment of chronic constipation.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  colonic transit; constipation; geometric center; scintigraphy

Mesh:

Year:  2020        PMID: 32394592      PMCID: PMC7483962          DOI: 10.1111/nmo.13878

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  18 in total

Review 1.  Measurement of gastrointestinal transit.

Authors:  Henry C Lin; Charlene Prather; Robert S Fisher; James H Meyer; Robert W Summers; Mark Pimentel; Richard W McCallum; Louis M A Akkermans; Vera Loening-Baucke
Journal:  Dig Dis Sci       Date:  2005-06       Impact factor: 3.199

2.  Emptying of the terminal ileum in intact humans. Influence of meal residue and ileal motility.

Authors:  R C Spiller; M L Brown; S F Phillips
Journal:  Gastroenterology       Date:  1987-03       Impact factor: 22.682

3.  Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice.

Authors:  G J Kolar; M Camilleri; D Burton; A Nadeau; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2013-10-10       Impact factor: 3.598

4.  A ne method for studying gut transit times using radioopaque markers.

Authors:  J M Hinton; J E Lennard-Jones; A C Young
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

Review 5.  Chronic constipation.

Authors:  Michael Camilleri; Alexander C Ford; Gary M Mawe; Phil G Dinning; Satish S Rao; William D Chey; Magnus Simrén; Anthony Lembo; Tonia M Young-Fadok; Lin Chang
Journal:  Nat Rev Dis Primers       Date:  2017-12-14       Impact factor: 52.329

6.  Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms.

Authors:  E S Bonapace; A H Maurer; S Davidoff; B Krevsky; R S Fisher; H P Parkman
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

7.  Simplified assessment of segmental colonic transit.

Authors:  A M Metcalf; S F Phillips; A R Zinsmeister; R L MacCarty; R W Beart; B G Wolff
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

Review 8.  Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies.

Authors:  S S C Rao; M Camilleri; W L Hasler; A H Maurer; H P Parkman; R Saad; M S Scott; M Simren; E Soffer; L Szarka
Journal:  Neurogastroenterol Motil       Date:  2011-01       Impact factor: 3.598

9.  Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation.

Authors:  M Camilleri; N K Thorne; Y Ringel; W L Hasler; B Kuo; T Esfandyari; A Gupta; S M Scott; R W McCallum; H P Parkman; E Soffer; G E Wilding; J R Semler; S S C Rao
Journal:  Neurogastroenterol Motil       Date:  2010-05-11       Impact factor: 3.598

10.  Investigation of colonic and whole-gut transit with wireless motility capsule and radiopaque markers in constipation.

Authors:  Satish S C Rao; Braden Kuo; Richard W McCallum; William D Chey; John K DiBaise; William L Hasler; Kenneth L Koch; Jeffrey M Lackner; Carrie Miller; Richard Saad; Jack R Semler; Michael D Sitrin; Gregory E Wilding; Henry P Parkman
Journal:  Clin Gastroenterol Hepatol       Date:  2009-05       Impact factor: 11.382

View more
  3 in total

1.  Cohort Study in Parkinsonism: Delayed Transit, Accelerated Gastric Emptying, and Prodromal Dysmotility.

Authors:  Katayoun Khoshbin; Anhar Hassan; Michael Camilleri
Journal:  Neurol Clin Pract       Date:  2021-08

Review 2.  Gastrointestinal motility disorders in patients with multiple sclerosis: A single-center study.

Authors:  Lehar Khanna; Burcu Zeydan; Orhun H Kantarci; Michael Camilleri
Journal:  Neurogastroenterol Motil       Date:  2022-02-03       Impact factor: 3.960

3.  Paeoniflorin Improved Constipation in the Loperamide-Induced Rat Model via TGR5/TRPA1 Signaling-Mediated 5-Hydroxytryptamine Secretion.

Authors:  Yu Zhan; Yong Wen; Liang-Liang Zhang; Xu-Long Shen; Xiao-Hui Chen; Xiao-Hai Wu; Xue-Gui Tang
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-08       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.